Atai Life Sciences N.V.
NASDAQ:ATAI
1.41 (USD) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 0.308 | 0.314 | 0.233 | 20.376 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0.168 | 0.047 | 0.024 | 0.006 |
| Gross Profit
| 0.308 | 0.314 | 0.065 | 20.329 | -0.024 | -0.006 |
| Gross Profit Ratio
| 1 | 1 | 0.279 | 0.998 | 0 | 0 |
| Reseach & Development Expenses
| 55.455 | 62.203 | 74.313 | 47.956 | 11.408 | 3.084 |
| General & Administrative Expenses
| 47.544 | 63.582 | 70.35 | 92.745 | 80.734 | 5.09 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 47.544 | 63.582 | 70.35 | 92.745 | 80.734 | 5.09 |
| Other Expenses
| 0 | 0 | 9.605 | -0.796 | -16.091 | 0.425 |
| Operating Expenses
| 102.999 | 125.785 | 144.663 | 140.701 | 92.142 | 8.174 |
| Operating Income
| -102.691 | -125.471 | -144.787 | -135.805 | -104.162 | 1.574 |
| Operating Income Ratio
| -333.412 | -399.589 | -621.403 | -6.665 | 0 | 0 |
| Total Other Income Expenses Net
| -45.714 | 86.185 | 9.605 | -0.796 | -74.158 | -6.534 |
| Income Before Tax
| -148.405 | -39.286 | -135.182 | -136.601 | -101.813 | -17.474 |
| Income Before Tax Ratio
| -481.834 | -125.115 | -580.18 | -6.704 | 0 | 0 |
| Income Tax Expense
| 0.356 | 1.016 | 6.229 | -3.989 | 0.305 | 0.002 |
| Net Income
| -149.269 | -40.224 | -141.411 | -132.612 | -102.118 | -17.476 |
| Net Income Ratio
| -484.64 | -128.102 | -606.914 | -6.508 | 0 | 0 |
| EPS
| -0.93 | -0.25 | -0.91 | -0.83 | -17.57 | -3.23 |
| EPS Diluted
| -0.93 | -0.25 | -0.91 | -0.83 | -17.57 | -3.23 |
| EBITDA
| -144.808 | -36.311 | -135.014 | -120.278 | -92.118 | -17.468 |
| EBITDA Ratio
| -470.156 | -115.64 | -579.459 | -5.903 | 0 | 0 |